ABNB Airbnb | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | $145.00 ➝ $155.00 | Neutral ➝ Neutral | |
ABNB Airbnb | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | $160.00 | Neutral ➝ Neutral | |
ABNB Airbnb | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | $145.00 ➝ $145.00 | Neutral ➝ Neutral | |
ABNB Airbnb | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.05 -6.9% | | Hold | |
ACAD ACADIA Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.21 -11.2% | $37.00 | Overweight ➝ Overweight | |
ACAD ACADIA Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.21 -11.2% | $30.00 | Buy ➝ Buy | |
|
ACMR ACM Research | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.29 -1.1% | $34.00 | Buy ➝ Buy | |
ACVA ACV Auctions | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.47 +0.9% | $23.00 | Buy ➝ Buy | |
AFRM Affirm | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.81 +10.2% | | Hold | |
AG First Majestic Silver | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.49 +5.3% | $8.50 | Buy ➝ Buy | |
ALEC Alector | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.20 +0.2% | | Overweight | |
AMPH Amphastar Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.43 +0.5% | | Hold | |
ANIK Anika Therapeutics | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.26 -11.3% | $37.00 ➝ $37.00 | Outperform ➝ Outperform | |
APP AppLovin | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.69 +14.4% | | Hold | |
AQST Aquestive Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.29 +6.8% | $9.00 | Buy ➝ Buy | |
ARHS Arhaus | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.50 +17.2% | $17.00 ➝ $17.00 | Outperform ➝ Outperform | |
ARM ARM | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 103.59 -2.3% | | Hold | |
AVBP ArriVent BioPharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Burns Subscribe to MarketBeat All Access for the recommendation accuracy rating | $17.99 +3.6% | $25.00 | Buy ➝ Buy | |
BKSY BlackSky Technology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Buck Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.21 +3.4% | $2.50 | Buy ➝ Buy | |
CAKE Cheesecake Factory | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.06 +6.2% | $44.00 | Overweight | |
CART Maplebear | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.09 -3.7% | $45.00 ➝ $47.00 | Overweight ➝ Overweight | |
CDNA CareDx | Reiterated by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.06 +8.6% | $15.00 | Buy ➝ Buy | |
CDXC ChromaDex | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.52 -8.1% | $6.00 | Buy ➝ Buy | |
CRSP CRISPR Therapeutics | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.55 +0.5% | $86.00 | Market Outperform ➝ Market Outperform | |
CRSP CRISPR Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.55 +0.5% | | Neutral | |
CTMX CytomX Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.04 -51.3% | | Neutral | |
CXW CoreCivic | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.49 +0.8% | $19.00 | Outperform ➝ Outperform | |
CYTK Cytokinetics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.02 -1.9% | $108.00 | Buy ➝ Buy | |
DVAX Dynavax Technologies | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.01 -5.5% | $29.00 | Buy ➝ Buy | |
ENLT Enlight Renewable Energy | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.12 +0.2% | $19.00 ➝ $20.00 | Buy ➝ Buy | |
ERAS Erasca | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.96 -8.8% | $8.00 | Buy ➝ Buy | |
FEMY Femasys | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.27 -8.6% | $13.00 | Buy ➝ Buy | |
FNA Paragon 28 | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.25 -13.2% | $18.00 ➝ $15.00 | Overweight ➝ Overweight | |
FTEK Fuel Tech | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.31 +0.8% | $4.00 | Buy ➝ Buy | |
FVRR Fiverr International | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +10.2% | $33.00 | Buy ➝ Buy | |
GAIN Gladstone Investment | Reiterated by | LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.09 -0.5% | $14.00 ➝ $14.00 | Buy ➝ Neutral | |
GENI Genius Sports | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.45 +1.3% | $9.00 | Buy ➝ Buy | |
GILT Gilat Satellite Networks | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57 -0.2% | $8.50 | Buy ➝ Buy | |
HL Hecla Mining | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.48 +11.6% | $10.25 | Buy ➝ Buy | |
HNST Honest | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.13 +6.1% | $4.00 ➝ $4.00 | Market Perform ➝ Market Perform | |
BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad) BREAKING - Pentagon to Spend $20 Billion on "Distributed AI"
The U.S. Space Force calls it a "game changer."
And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>> |
HUBS HubSpot | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $587.34 -0.5% | $730.00 | Buy ➝ Buy | |
HY Hyster-Yale Materials Handling | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $79.11 +8.5% | $85.00 ➝ $87.00 | Buy ➝ Buy | |
IFRX InflaRx | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.20
| $8.00 | Buy ➝ Buy | |
IGMS IGM Biosciences | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.12 +8.4% | $20.00 | Outperform ➝ Outperform | |
IMCR Immunocore | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.85 -2.4% | $81.00 | Buy ➝ Buy | |
IMXI International Money Express | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.12 +5.5% | $25.00 | Buy ➝ Buy | |
IONQ IonQ | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.20 +4.8% | $18.00 | Buy ➝ Buy | |
IPAR Inter Parfums | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.59 +1.8% | $192.00 ➝ $192.00 | Buy ➝ Buy | |
JAMF Jamf | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.95 +1.2% | $25.00 | Buy ➝ Buy | |
JANX Janux Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.94 -6.2% | $100.00 | Overweight ➝ Overweight | |
KMDA Kamada | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.56 -3.1% | $11.00 | Buy ➝ Buy | |
KPTI Karyopharm Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.07 +4.9% | $8.00 | Buy ➝ Buy | |
KRNT Kornit Digital | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.57 +2.6% | $27.00 | Buy ➝ Buy | |
KROS Keros Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.60 -1.1% | $100.00 | Buy ➝ Buy | |
KVYO Klaviyo | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.97 +11.3% | $40.00 | Buy ➝ Buy | |
KVYO Klaviyo | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.97 +11.3% | $31.00 | Overweight ➝ Overweight | |
LEGN Legend Biotech | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.52 -0.4% | $87.00 | Buy ➝ Buy | |
LESL Leslie's | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.19 +10.7% | $6.00 ➝ $6.00 | Market Perform ➝ Market Perform | |
LPSN LivePerson | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.58 -7.9% | | Hold | |
LVLU Lulu's Fashion Lounge | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.78 +16.3% | $3.00 ➝ $3.00 | Market Perform ➝ Market Perform | |
MEG Montrose Environmental Group | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.05 -0.5% | $54.00 | Buy ➝ Buy | |
MGNI Magnite | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.23 +3.7% | $15.00 | Buy ➝ Buy | |
MIRM Mirum Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.83 +3.2% | $40.00 | Overweight ➝ Overweight | |
MIRM Mirum Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.83 +3.2% | $58.00 | Buy ➝ Buy | |
MNKD MannKind | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.31 -2.0% | $6.50 | Overweight ➝ Overweight | |
MRUS Merus | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.12 -4.2% | $65.00 | Buy ➝ Buy | |
NABL N-able | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.93 +2.1% | $16.50 | Buy ➝ Buy | |
NI NiSource | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.90 +0.6% | $30.00 ➝ $31.00 | Outperform ➝ Outperform | |
NPCE NeuroPace | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Osborn Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.97 -36.7% | $18.00 | Overweight ➝ Overweight | |
NVEE NV5 Global | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $96.13 +2.3% | $121.00 ➝ $128.00 | Buy ➝ Buy | |
PCVX Vaxcyte | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $65.57 -1.8% | | Overweight | |
PCVX Vaxcyte | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.57 -1.8% | $95.00 | Buy ➝ Buy | |
PDSB PDS Biotechnology | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.83 -4.7% | | Overweight | |
PDSB PDS Biotechnology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.83 -4.7% | $21.00 | Buy ➝ Buy | |
PERI Perion Network | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.22 -3.4% | $18.00 | Buy ➝ Buy | |
PHAT Phathom Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.09 -0.1% | $26.00 | Buy ➝ Buy | |
PMT PennyMac Mortgage Investment Trust | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.72 +0.8% | $14.50 ➝ $15.00 | Neutral ➝ Neutral | |
PSNL Personalis | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.65 +5.1% | $3.50 | Buy ➝ Buy | |
PTGX Protagonist Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.27 +4.3% | $38.00 | Buy ➝ Buy | |
PWSC PowerSchool | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.12 -5.4% | $25.00 | Overweight | |
PYCR Paycor HCM | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.76 -15.7% | $42.00 | Buy ➝ Buy | |
PYPD PolyPid | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.50 +4.4% | $14.00 | Buy ➝ Buy | |
PZZA Papa John's International | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.22 -6.8% | $75.00 | Overweight ➝ Overweight | |
RCUS Arcus Biosciences | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.15 +5.8% | $30.00 | Outperform ➝ Outperform | |
RDWR Radware | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.72 +2.9% | | Hold | |
RITM Rithm Capital | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.31 +0.8% | $13.00 | Outperform ➝ Outperform | |
RMBL RumbleOn | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.17 +13.2% | $7.00 | Outperform ➝ Outperform | |
RNAC Cartesian Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $21.86 -6.0% | $54.00 | Buy ➝ Buy | |
RNG RingCentral | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.46 +3.1% | $40.00 | Neutral ➝ Neutral | |
RVMD Revolution Medicines | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.45 -2.2% | $46.00 | Buy ➝ Buy | |
The ONE AI Stock to own now. (It’s not Nvidia.) (Ad) Don’t panic — you haven’t missed the boat on AI.
In fact, it has barely launched.
Sure, the early stages of this boom were big …
But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. |
SANA Sana Biotechnology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.50 -21.0% | $12.00 | Buy ➝ Buy | |
SGHC Super Group | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.50
| $6.00 | Buy ➝ Buy | |
SHOP Shopify | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.47 -0.4% | | Hold | |
SNDX Syndax Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.97 -1.8% | $41.00 | Buy ➝ Buy | |
STE STERIS | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $226.04 +7.6% | $265.00 | Market Outperform ➝ Market Outperform | |
STNG Scorpio Tankers | Reiterated by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.76 +1.8% | $90.00 ➝ $90.00 | Buy ➝ Buy | |
TFC Truist Financial | Reiterated by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.10 +0.6% | $44.00 | In-Line | |
TNGX Tango Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.77 -1.8% | $17.00 | Buy ➝ Buy | |
TPR Tapestry | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.37 +3.6% | $54.00 ➝ $54.00 | Outperform ➝ Outperform | |
TTD Trade Desk | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.67 +3.1% | $105.00 ➝ $110.00 | Overweight ➝ Overweight | |
TTD Trade Desk | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.67 +3.1% | $100.00 | Buy ➝ Buy | |
TTD Trade Desk | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.67 +3.1% | $107.00 ➝ $108.00 | Outperform ➝ Outperform | |
USPH U.S. Physical Therapy | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.08 +1.1% | $122.00 ➝ $122.00 | Outperform ➝ Outperform | |
VERV Verve Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $6.36 +4.6% | $15.00 | Buy ➝ Buy | |
VLN Valens Semiconductor | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.49 +1.2% | $4.00 ➝ $4.00 | Buy ➝ Buy | |
VRDN Viridian Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.91 -6.6% | $30.00 | Buy ➝ Buy | |
WRBY Warby Parker | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.68 +18.0% | $19.00 ➝ $19.00 | Outperform ➝ Outperform | |
XPER Xperi | Reiterated by | BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.14 -6.6% | $30.00 ➝ $30.00 | Top Pick ➝ Top Pick | |
YOU Clear Secure | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.90 +4.2% | $34.00 ➝ $34.00 | Outperform ➝ Outperform | |
ZIMV ZimVie | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.97 +10.3% | | Hold | |